Literature DB >> 31152447

MicroRNA-200c promotes osteogenic differentiation of human bone mesenchymal stem cells through activating the AKT/β-Catenin signaling pathway via downregulating Myd88.

Peng Xia1, Rui Gu2, Wei Zhang1, Liwei Shao2, Fang Li2, Changyan Wu2, Yifu Sun2.   

Abstract

During the human bone formation, the event of osteogenic differentiation of human bone mesenchymal stem cells (hBMSCs) is vital, and recent evidence has emphasized the important role of microRNAs (miRNAs) in osteogenic differentiation of hBMSCs. This study aims to examine the potential effects of miR-200c in osteogenic differentiation of hBMSCs and understand their underlying mechanisms. HBMSCs were obtained via human bone marrow. During osteogenic induction and differentiation, cells were transfected with different plasmids with the intention of investigating the roles of miR-200c on osteogenic differentiation, calcium salt deposition, alkaline-phosphatase (ALP) activity, mineralized nodule formation, osteocalcin (OCN) content, and proliferation of osteoblasts. Following transfection, dual luciferase reporter gene assay was conducted so as to explore the correlation between miR-200c and Myd88. Moreover, the AKT/β-Catenin signaling pathway was blocked with an AKT/β-Catenin inhibitor, AKTi, to investigate its involvement. The hBMSCs were successfully isolated from human bone marrow. Myd88 was determined as a target gene of miR-200c. Gain and loss-of-function assays confirmed that overexpression of miR-200c, or silencing of Myd88 promoted osteogenic differentiation, increased calcium salt deposition, ALP activity, mineralized nodule formation, and enhanced the proliferation of osteoblasts following osteogenic differentiation of hBMSCs. Meanwhile, the downregulation of miR-200c has been shown to have the opposite effect. Furthermore, these findings showed that the miR-200c overexpression activated the AKT/β-Catenin signaling pathway by targeting Myd88. To sum up, the miR-200c upregulation induces osteogenic differentiation of hBMSCs by activating the AKT/β-Catenin signaling pathway via the inhibition of Myd88, providing a target for treatment of bone repair.
© 2019 Wiley Periodicals, Inc.

Entities:  

Keywords:  AKT/β-Catenin signaling pathway; human bone mesenchymal stem cells; microRNA-200c; myeloid differentiation factor 88; osteoblast differentiation

Mesh:

Substances:

Year:  2019        PMID: 31152447     DOI: 10.1002/jcp.28834

Source DB:  PubMed          Journal:  J Cell Physiol        ISSN: 0021-9541            Impact factor:   6.384


  6 in total

Review 1.  The Emerging Role of Non-Coding RNAs in Osteogenic Differentiation of Human Bone Marrow Mesenchymal Stem Cells.

Authors:  Xiaoying Chen; Wei Xie; Ming Zhang; Yuhan Shi; Shaofen Xu; Haoyu Cheng; Lihong Wu; Janak L Pathak; Zhichao Zheng
Journal:  Front Cell Dev Biol       Date:  2022-05-16

2.  Plasmid encoding microRNA-200c ameliorates periodontitis and systemic inflammation in obese mice.

Authors:  Tadkamol Krongbaramee; Min Zhu; Qingwen Qian; Zeyuan Zhang; Steven Eliason; Yi Shu; Fang Qian; Adil Akkouch; Dan Su; Brad A Amendt; Ling Yang; Liu Hong
Journal:  Mol Ther Nucleic Acids       Date:  2021-02-04       Impact factor: 8.886

Review 3.  Roles of MicroRNAs in Bone Destruction of Rheumatoid Arthritis.

Authors:  Hanxiao Zhao; Aiping Lu; Xiaojuan He
Journal:  Front Cell Dev Biol       Date:  2020-11-19

4.  Stage-Dependent Activity and Pro-Chondrogenic Function of PI3K/AKT during Cartilage Neogenesis from Mesenchymal Stromal Cells.

Authors:  Felicia A M Klampfleuthner; Benedict Lotz; Tobias Renkawitz; Wiltrud Richter; Solvig Diederichs
Journal:  Cells       Date:  2022-09-23       Impact factor: 7.666

5.  Expression of miR-204 in patients with osteoarthritis and its damage to chondrocytes.

Authors:  Xiaodong Liu; Feng Gao; Weikang Wang; Jinglong Yan
Journal:  J Musculoskelet Neuronal Interact       Date:  2020-06-01       Impact factor: 2.041

Review 6.  The Role of MicroRNAs in Bone Metabolism and Disease.

Authors:  Yongguang Gao; Suryaji Patil; Airong Qian
Journal:  Int J Mol Sci       Date:  2020-08-24       Impact factor: 5.923

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.